Primidone Suppliers & Bulk Manufacturers
Available Forms: Tablets, Capsules
Available Strengths: 50 mg , 250 mg
Reference Brands: Mysoline (USA)
Category:
Neurology
Primidone is available in Tablets, Capsules
and strengths such as 50 mg , 250 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Primidone is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Primidone can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Primidone is an aromatic anticonvulsant medication that plays an important role in the long-term management of epilepsy and related seizure disorders. It has been in clinical use for several decades and remains a valuable therapeutic option for patients who require effective seizure control, either as monotherapy or in combination with other antiepileptic drugs. Primidone is particularly useful in the treatment of generalized tonic-clonic seizures and partial seizures, including simple and complex partial seizures, and it also has documented efficacy in myoclonic seizures. In certain epilepsy subtypes, such as juvenile myoclonic epilepsy, primidone is considered a second-line therapy and is typically reserved for patients who do not respond adequately to first-line agents such as valproates or lamotrigine.
Pharmacologically, primidone exerts its antiepileptic effects through its active metabolites, phenobarbital and phenylethylmalonamide (PEMA). These metabolites contribute significantly to its therapeutic activity by enhancing inhibitory neurotransmission within the central nervous system and reducing abnormal neuronal firing. Through these mechanisms, primidone helps stabilize neuronal membranes and suppress the excessive electrical discharges responsible for seizure activity. The gradual formation of active metabolites also explains the need for careful dose titration and monitoring during therapy.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing